Picton Mahoney Asset Management’s Haemonetics HAE Stock Holding History

Picton Mahoney Asset Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-63,820	Closed	-$5.71M	–	360
2020 Q2	$5.71M	Sell	63,820 -29,720	-32%	-$3M	0.33%	92
2020 Q1	$9.32M	Sell	93,540 -24,200	-21%	-$2.62M	0.53%	50
2019 Q4	$13.5M	Sell	117,740 -8,100	-6%	-$980K	0.91%	32
2019 Q3	$15.9M	Sell	125,840 -7,860	-6%	-$998K	1.12%	28
2019 Q2	$16.1M	Sell	133,700 -560	-0.4%	-$55.1K	1.1%	31
2019 Q1	$11.7M	Sell	134,260 -29,391	-18%	-$2.67M	0.89%	40
2018 Q4	$16.4M	Sell	163,651 -2,997	-2%	-$315K	1.46%	20
2018 Q3	$19.1M	Sell	166,648 -2,152	-1%	-$223K	1.34%	24
2018 Q2	$15.1M	Buy	168,800 +15,000	+10%	+$1.27M	1.09%	32
2018 Q1	$11.3M	Buy	153,800 +121,000	+369%	+$8.3M	0.81%	47
2017 Q4	$1.91M	Buy	+32,800	New	+$1.73M	0.14%	121

Other funds holding HAE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Picton Mahoney Asset Management's HAE Position: Q3 2020 in Review

Picton Mahoney Asset Management sold out of Haemonetics (HAE) in Q3 2020, closing a stake of 63,820 shares — an estimated $5.71M sold.

Picton Mahoney Asset Management first reported a position in HAE in Q4 2017 and held it in 11 quarters. The position peaked at $19.1M in Q3 2018. 268 funds tracked by Wall St. Rank hold HAE as of Q3 2020.

Picton Mahoney Asset Management reported no remaining Haemonetics position as of Q3 2020 after selling out during the quarter.
Picton Mahoney Asset Management sold 63,820 Haemonetics shares in Q3 2020, an estimated $5.71M.
Picton Mahoney Asset Management first reported a position in Haemonetics in Q4 2017 and held it in 11 quarters.
Picton Mahoney Asset Management's Haemonetics position peaked at $19.1M in Q3 2018.
268 funds tracked by Wall St. Rank held Haemonetics as of Q3 2020.

Based on Picton Mahoney Asset Management's 13F filing for Q3 2020, filed 2 Nov 2020.